Seroatlas · Human Serome Atlas

TNFRSF13B

Tumor necrosis factor receptor superfamily member 13B

Also known as: CD267, IGAD2, TACI, TR13B_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O14836
Gene
TNFRSF13B
Ensembl
ENSG00000240505
Chromosome
17
Canonical length
293 aa
Protein class
CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins

OverviewNCBI Gene

The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

293 residues, UniProt reviewed canonical sequence.

>O14836|TNFRSF13B
     1  MSGLGRSRRG GRSRVDQEER FPQGLWTGVA MRSCPEEQYW DPLLGTCMSC KTICNHQSQR
    61  TCAAFCRSLS CRKEQGKFYD HLLRDCISCA SICGQHPKQC AYFCENKLRS PVNLPPELRR
   121  QRSGEVENNS DNSGRYQGLE HRGSEASPAL PGLKLSADQV ALVYSTLGLC LCAVLCCFLV
   181  AVACFLKKRG DPCSCQPRSR PRQSPAKSSQ DHAMEAGSPV STSPEPVETC SFCFPECRAP
   241  TQESAVTPGT PDPTCAGRWG CHTRTTVLQP CPHIPDSGLG IVCVPAQEGG PGA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TNFRSF13B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.62
Highest tissue expression
59 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 59 nTPM
  • spleen: 30 nTPM
  • tonsil: 21 nTPM
  • small intestine: 17 nTPM
  • lymph node: 15 nTPM
  • appendix: 8.1 nTPM

Single-cell type

  • plasma cells: 177 nCPM
  • b-cells: 133 nCPM
  • platelets: 11 nCPM
  • gastric chief cells: 6.6 nCPM
  • pdcs: 6.5 nCPM
  • foveolar cells: 4.3 nCPM

Immune cell

  • memory B-cell: 131 nTPM
  • naive B-cell: 52 nTPM
  • total PBMC: 2.7 nTPM
  • T-reg: 2.2 nTPM
  • neutrophil: 0.5 nTPM
  • basophil: 0.1 nTPM

Brain region

  • white matter: 3 nTPM
  • pons: 2.5 nTPM
  • basal ganglia: 1.5 nTPM
  • cerebral cortex: 1.5 nTPM
  • medulla oblongata: 1.5 nTPM
  • thalamus: 1.4 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about TNFRSF13B.

Disease | AllUniProt

Conditions TNFRSF13B is implicated in, by any mechanism.

Disease | GeneticClinVar

34 pathogenic / likely-pathogenic of 380 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.96
gnomAD pLI
0
gnomAD missense Z
-1.2
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • TACI, cysteine-rich domain
  • Tumour necrosis factor receptor 13B
  • TACI, cysteine-rich domain

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TNFRSF13B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TNFRSF13B as an antibody target. Whether an autoantibody or antibody against TNFRSF13B could matter depends on whether native TNFRSF13B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TNFRSF13B is annotated at the cell surface, where native TNFRSF13B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Source-annotated serology context

The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.

  • The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand.

Canonical record: https://seroatlas.com/gene/TNFRSF13B. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...